Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 2/20 | 0.46 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.46 |
| ▸ | PDE4C | Q08493 | 2/20 | 0.46 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.46 |
| ▸ | ANPEP | P15144 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | PPARG | P37231 | 1/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.38 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.38 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL403896 | 1.00 | PDE4A (0.46) | PDE4APDE4BPDE4CPDE4DANPEP | |
| SCHEMBL403455 | 0.89 | PDE4A (0.46) | PDE4APDE4BPDE4CPDE4DANPEP | |
| SCHEMBL1095574 | 0.85 | PDE4A (0.53) | PDE4APDE4BPDE4CPDE4DANPEP | |
| SCHEMBL404144 | 0.82 | TAS1R3 (0.51) | PDE4APDE4BPDE4CPDE4DANPEP | |
| SCHEMBL12837593 | 0.82 | TAS1R3 (0.51) | PDE4APDE4BPDE4CPDE4DANPEP | |
| SCHEMBL4532170 | 0.79 | PDE4A (0.45) | PDE4APDE4BPDE4CPDE4DANPEP | |
| SCHEMBL13654568 | 0.78 | PDE4A (0.45) | PDE4APDE4BPDE4CPDE4DANPEP | |
| SCHEMBL5450568 | 0.78 | CA2 (0.49) | ANPEPPPARG | |
| SCHEMBL405181 | 0.78 | CA2 (0.49) | ANPEPPPARG | |
| SCHEMBL1096818 | 0.78 | ANPEP (0.56) | ANPEPPPARGALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8153843-B2 | Antibacterial agents | UNIVERSITY OF WASHINGTON (US) | 2012-04-10 | — | — | US | disclosed |
| US-8101640-B2 | Antibacterial agents | NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) | 2012-01-24 | — | — | US | disclosed |
| US-7989660-B2 | BACTERICIDE AGAINST GRAMNEGATIVE BACTERIA; RESPIARATORY SYSTEM DISORDERS | NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) | 2011-08-02 | — | — | US | disclosed |
| US-20110172174-A1 | Antibacterial agents | NOVARTIS VACCINES AND DIAGNOSTICS INC. | 2011-07-14 | — | — | US | disclosed |
| US-20100324025-A1 | Antibacterial Agents | UNIVERSITY OF WASHINGTON (US) | 2010-12-23 | — | — | US | disclosed |
| US-20080269221-A1 | ANTIBACTERIAL AGENTS | NOVARTIS VACCINES AND DIAGNOSTICS, INC. | 2008-10-30 | — | — | US | disclosed |
| US-7358359-B2 | Antibacterial agents | UNIVERSITY OF WASHINGTON (US) | 2008-04-15 | — | — | US | disclosed |
| US-20070244197-A1 | Antibacterial agents | UNIVERSITY OF WASHINGTON (US) | 2007-10-18 | — | — | US | disclosed |
| US-20060154988-A1 | Antibacterial agents | UNIVERSITY OF WASHINGTON (US) | 2006-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070244197-A1 | Antibacterial agents | MRPL21, SI, PGLS | PDE4A 1478/4885PDE4B 1203/4885PDE4C 1615/4885 |
| US-20110172174-A1 | Antibacterial agents | MRPL21, SI, PGLS | PDE4A 1478/4885PDE4B 1203/4885PDE4C 1615/4885 |
| US-20080269221-A1 | ANTIBACTERIAL AGENTS | MRPL21, SI, PGLS | PDE4A 1478/4885PDE4B 1203/4885PDE4C 1615/4885 |
| US-20060154988-A1 | Antibacterial agents | MRPL21, SI, PGLS | PDE4A 1478/4885PDE4B 1203/4885PDE4C 1615/4885 |
| US-20100324025-A1 | Antibacterial Agents | MRPL21, SI, PGLS | PDE4A 1478/4885PDE4B 1203/4885PDE4C 1615/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.